Pharmacokinetics of quinine in patients with chronic renal failure

European Journal of Clinical Pharmacology

Volumn 49, Issue 6, 1996, Pages 497-501

  Rimchala, P ^a   Karbwang, J ^b   Sukontason, K ^b   Banmairuroi, V ^b   Molunto, P ^b   Na Bangchang, K ^b  

^a PRAPOKKLAO HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic renal failure; Malaria; Pharmacokinetics; Quinine

Indexed keywords

QUININE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0029962755     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00195937     Document Type: Article

References (33)

1. Bunnag D, Harinasuta T (1987) Quinine and quinidine in malaria in Thailand. Acta Leidensia 55:163-166
2. Warrell DA, Molyneux ME, Beales PF (eds) (1990) Severe and complicated malaria. Trans R Soc Trop Med Hyg 84 [Suppl]: 1-65
3. Karbwang J, Harinasuta T (1992) Chemotherapy of malaria in Southeast Asia. Ruamtasana Co. Ltd., Bangkok
4. World Health Organization (1990) The clinical management of acute malaria. WHO Regional Publications, Southeast Asia Series No. 9
5. White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinasuta T (1982) Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 73:564-572
6. Karbwang J, Thanavibul A, Molunto P, Na-Bangchang K (1993) The pharmacokinetics of quinine in patients with hepatitis. Br J Clin Pharmacol 35:444-446
7. Auprayoon P, Sukontason K, Karbwang J, Banmairuroi V, Molunto P, Na-Bangchang K (1995) Pharmacokinetics of quinine in chronic liver disease. Br J Clin Pharmacol 40:494-497
8. Brodie BB, Baer JE, Craig LC (1951) Metabolic products of the cinchona alkaloids in human urine. J Biol Chem 88: 567-581
9. Wattanagoon Y, Molunto P, Bunnag D, Na-Bangchang K, Karbwang J (1990) Effect of metoclopramide on quinine pharmacokinetics. Abstract "VIII International Congress of Parasitology. Paris, August 20-24, p 1073
10. Karbwang J, Na-Bangchang K, Molunto P, Bunnag D (1989) Determination of quinine and quinidine in biological fluids by high performance liquid chromatography. Southeast Asian J Trop Med Public Health 20:65-79
11. Silamut K, White NJ, Looareesuwan S, Warrell DA (1985) Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 34:681-686
12. Gibaldi M (1991) Biopharmaceutics and clinical pharmacokinetics, 4th edn. Lee and Febiger, UK, pp 14-23
13. Notterman DA, Drayer DE, Metakis L, Reidenberg MM (1986) Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther 4(5):511-517
14. Paap CM, Nahata MC (1993) The relation between type of renal disease and renal drug clearance in children. Eur J Clin Pharmacol 44:195-197
15. Trenholme GM, Williams RL, Rieckmann KH, Frisher H, Carson PE (1976) Quinine disposition during malaria and during induced fever. Clin Pharmacol The: 19:459-467
16. Chau NP, Weiss YA, Safar ME, Lavene DE, Georges DR, Milliez PL (1977) Pindolol availability in hypertensive patients with normal and impaired renal function. Clin Pharmacol Ther 222:505-510
17. Tilstone WJ, Fine A (1978) Furosemide kinetics in renal failure. Clin Pharmacol Ther 23:499-508
18. Na-Bangchang K, Karbwang J, Bunnag D, Harinasuta T (1991) The effect of metoclopramide on mefloquine pharmacokinetics. Br J Clin Pharmacol 32:640-641
19. Reindenberg MM (1977) The biotransformation of drugs in renal failure. Am J Med 62:482-485
20. Verbeeck RK, Branch RA, Wilkinson GR (1981) Drug metabolites in renal failure. Clin Pharmacokinet 6:329-345
21. Krishna DR, Klotz U (1990) Basic pharmacokinetics elimination. In Krishna DR, Klotz U (eds) Clinical pharmacokinetics. Springer, Berlin Heidelberg New York, pp 38-57
22. Reindenberg MM, Drayer DE (1984) Alteration of drug protein binding in renal disease. Clin Pharmacokinet 9 [Suppl 1]: 18-26
23. Haughey DB, Kraft CJ, Matzke GR, Keane WF, Halstenson CE (1985) Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Am J Nephron 5: 35-39
24. Kim YG, Shin JG, Shin SG (1993) Decreased acetylation of isoniazid in chronic renal failure. Clin Pharmacol Ther 54: 612-620
25. Mueller BA, Scarim SK, Macias WE (1993) Comparison of imipenam pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration. Am J Kidney Dis 73:172-179
26. Guengerich FP, Muller-Enoch D, Blair IA (1986) Oxidation of quinidine by human liver cytochrome P-450. J Pharmacol Exp Ther 30:287-295
27. Anders MW (1980) Metabolism of drugs by the kidney. Kid Int. 18: 636-647.
28. Gibson TP (1986) Renal disease and drug metabolism: an overview. Am J Kid Dis 8:7-17
29. Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT, Burke MD (1988) The immunochemical localization and distribution of cytochrome P450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P450. Br J Clin Pharmacol 25:165-175
30. Kolar JC, Schmiedin-Ren P, Scmiedin-Ren P, Schmiedin-Ren P, Schuetz JD, Watkins PB (1992) Identification of rifampicin-inducible p450IIIa4 (cyp3a4) in human small bowel enterocytes. J Clin Invest 90:1871-1878
31. Dyson EH, Proudfoot AT, Prescott LF (1985) Death and blindness due to overdose of quinine. Br Med J 291:31-33
32. World Health Organization (1984) Advance in malaria chemotherapy. WHO Tech Rep Series 711:91-151
33. Hashiba K, Moss AJ, Schwartz PJ (1991) QT prolongation and ventricular arrhythmias. Ann New York Acad Sc 664 [Suppl]: 1-247